Genus Capital Management Inc. Boston Scientific Corp Transaction History
Genus Capital Management Inc.
- $862 Billion
- Q3 2025
A detailed history of Genus Capital Management Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Genus Capital Management Inc. holds 29,047 shares of BSX stock, worth $2.98 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
29,047
Previous 51,412
43.5%
Holding current value
$2.98 Million
Previous $5.52 Billion
48.65%
% of portfolio
0.33%
Previous 0.7%
Shares
3 transactions
Others Institutions Holding BSX
# of Institutions
1,950Shares Held
1.26BCall Options Held
10.9MPut Options Held
8.94M-
Vanguard Group Inc Valley Forge, PA138MShares$14.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.9MShares$6.67 Billion0.23% of portfolio
-
Bank Of America Corp Charlotte, NC33.9MShares$3.48 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA33.1MShares$3.4 Billion2.56% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...